Search Results - "Chester, Kerry"
-
1
A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy
Published in Nature communications (31-03-2015)“…Although recent methods for the engineering of antibody–drug conjugates (ADCs) have gone some way to addressing the challenging issues of ADC construction,…”
Get full text
Journal Article -
2
The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity
Published in Cancer Immunology, Immunotherapy (01-11-2017)“…The primary aim of this clinical trial was to determine the feasibility of delivering first-generation CAR T cell therapy to patients with advanced, CEACAM5 +…”
Get full text
Journal Article -
3
Stromal features are predictive of disease mortality in oral cancer patients
Published in The Journal of pathology (01-03-2011)“…Worldwide, approximately 405 000 cases of oral cancer (OSCC) are diagnosed each year, with a rising incidence in many countries. Despite advances in surgery…”
Get full text
Journal Article -
4
Tuning the Hydrolytic Stability of Next Generation Maleimide Cross-Linkers Enables Access to Albumin-Antibody Fragment Conjugates and tri-scFvs
Published in Bioconjugate chemistry (21-02-2018)“…We describe investigations to expand the scope of next generation maleimide cross-linkers for the construction of homogeneous protein–protein conjugates…”
Get full text
Journal Article -
5
Next generation maleimides enable the controlled assembly of antibody-drug conjugates via native disulfide bond bridging
Published in Organic & biomolecular chemistry (07-10-2014)“…The advent of Adcetris™ and Kadcyla™, two recently FDA-approved antibody-drug conjugates (ADCs), in the clinic has had a major impact on the treatment of…”
Get more information
Journal Article -
6
A Simple and Robust Single-Step Method for CAR-Vδ1 γδT Cell Expansion and Transduction for Cancer Immunotherapy
Published in Frontiers in immunology (31-05-2022)“…The γδT cell subset of peripheral lymphocytes exhibits potent cancer antigen recognition independent of classical peptide MHC complexes, making it an…”
Get full text
Journal Article -
7
Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant
Published in Molecular therapy (05-06-2024)“…Stem cell gene therapy and hematopoietic stem cell transplantation (SCT) require conditioning to ablate the recipient's hematopoietic stem cells (HSCs) and…”
Get more information
Journal Article -
8
Potential of Magnetic Hyperthermia to Stimulate Localized Immune Activation
Published in Small (Weinheim an der Bergstrasse, Germany) (01-04-2021)“…Magnetic hyperthermia (MH) harnesses the heat‐releasing properties of superparamagnetic iron oxide nanoparticles (SPIONs) and has potential to stimulate immune…”
Get full text
Journal Article -
9
Granzyme B Functionalized Nanoparticles Targeting Membrane Hsp70‐Positive Tumors for Multimodal Cancer Theranostics
Published in Small (Weinheim an der Bergstrasse, Germany) (01-03-2019)“…Functionalized superparamagnetic iron oxide nanoparticles (SPIONs) have emerged as potential clinical tools for cancer theranostics. Membrane‐bound 70 kDa heat…”
Get full text
Journal Article -
10
Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance
Published in Nature communications (07-10-2022)“…Human papillomavirus (HPV)-associated cervical cancer is a leading cause of cancer deaths in women. Here we present an integrated multi-omic analysis of 643…”
Get full text
Journal Article -
11
Acid-cleavable thiomaleamic acid linker for homogeneous antibody-drug conjugation
Published in Chemical communications (Cambridge, England) (01-01-2013)“…In this communication we describe a novel acid-cleavable linker strategy for antibody-drug conjugation. Functional disulfide bridging of the single interchain…”
Get more information
Journal Article -
12
A vector-encoded bispecific killer engager to harness virus-activated NK cells as anti-tumor effectors
Published in Cell death & disease (10-02-2023)“…Treatment with oncolytic measles vaccines (MV) elicits activation of immune cells, including natural killer (NK) cells. However, we found that MV-activated NK…”
Get full text
Journal Article -
13
Homogeneous Bispecifics by Disulfide Bridging
Published in Bioconjugate chemistry (20-08-2014)“…We report on a chemical platform to generate site-specific, homogeneous, antibody–antibody conjugates by targeting and bridging disulfide bonds. A bispecific…”
Get full text
Journal Article -
14
scFv biofunctionalized nanoparticles to effective and safe targeting of CEA-expressing colorectal cancer cells
Published in Journal of nanobiotechnology (02-10-2023)“…Abstract Colorectal cancer (CRC) is one of the deadliest cancers worldwide, with the 5 year survival rate in metastatic cases limited to 12%. The design of…”
Get full text
Journal Article -
15
Antibody-drug conjugates - a perfect synergy
Published in Expert opinion on biological therapy (01-09-2012)“…There is a great unmet need for effective new treatments in cancer, which continues to be a major cause of death. Antibody-drug conjugates (ADCs) are emerging,…”
Get more information
Journal Article -
16
Aryloxymaleimides for cysteine modification, disulfide bridging and the dual functionalization of disulfide bonds
Published in Chemical communications (Cambridge, England) (11-07-2014)“…Tuning the properties of maleimide reagents holds significant promise in expanding the toolbox of available methods for bioconjugation. Herein we describe…”
Get more information
Journal Article -
17
Preclinical evaluation of a novel CEA‐targeting near‐infrared fluorescent tracer delineating colorectal and pancreatic tumors
Published in International journal of cancer (15-10-2015)“…Surgery is the cornerstone of oncologic therapy with curative intent. However, identification of tumor cells in the resection margins is difficult, resulting…”
Get full text
Journal Article -
18
Targeted photodynamic therapy with multiply‐loaded recombinant antibody fragments
Published in International journal of cancer (01-03-2008)“…Current photodynamic therapy (PDT) of cancer is limited by inefficiencies involved in specifically targeting photosensitizers to tumors. Although antibodies…”
Get full text
Journal Article -
19
Homogeneous antibody fragment conjugation by disulfide bridging introduces ‘spinostics’
Published in Scientific reports (22-03-2013)“…A major obstacle to the efficient production of antibody conjugates for therapy and diagnosis is the non-ideal performance of commonly used chemical methods…”
Get full text
Journal Article -
20
A novel anti-B7-H3 chimeric antigen receptor from a single-chain antibody library for immunotherapy of solid cancers
Published in Molecular therapy. Oncolytics (15-09-2022)“…B7-H3 (CD276) has emerged as a target for cancer immunotherapy by virtue of consistent expression in many malignancies, relative absence from healthy tissues,…”
Get full text
Journal Article